Navigation Links
NHS Recommends Further Cost Cutting Measures

Acting head of the NHS, Sir Ian Carruthers, has proposed cost cutting measures to reduce the estimated £750 million NHS deficit//.

He proposes to unveil his plan at a No 10 seminar to the Prime Minister Tony Blair. Sir Ian believes the £10.3 billion spent every year on drugs and the £1 billion on temporary staff need to be reduced. Fears that patients would not be given expensive treatments from which they could benefit have arisen.

NHS had been undertaking several staff cutting moves over the last few months. A study, due to be released, has predicted that with the emerging reforms staff has been expected to fall by at least 100,000.

The study has called for a review of training plans for doctors because of the predicted medical unemployment.

According to the Reform team, led by Nick Bosanquet, Professor of Health Policy at Imperial College, London the total NHS staff had risen to 1.33 million by 2004showing an increase of 45,000 a year since 1999. .

The report had suggested that it the costs of the expansion were the reason why the health service was being driven into deficit, the.

With the government’s reform agenda widespread effects were expected across the NHS. The reforms include payment by results, patient choice and the spread of foundation hospitals. There would also probably be an end to centralized contract negotiations, which was a key feature of recent NHS history.

Professor Bosanquet has opined that these reforms would benefit staff as well as patients although he expressed concern about job prospects for young doctors.

With the funding situation only likely to worsen in the next couple of years medical graduates would face more difficulty in getting employment. The graduate numbers would only continue to outweigh retirees massively and NHS financial situation being what it is will be creating fewer job posts and more staff reductions.
br>
'"/>




Page: 1

Related medicine news :

1. Journal Recommends How To Improve The Performance Of Health Workers
2. FDA Recommends Strong Warning Labels On the ADHD Drugs
3. European Medicines Agency (EMEA) Recommends Herceptin For Early Stage Breast Cancer
4. Further support for use of statins in Alzheimer’s disease
5. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
6. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
7. Medha Patkars Condition Deteriorates Further
8. Oxford Radcliffe Hospitals Warns Of Further Job Losses
9. Further Studies Needed To Completely Understand About Ventricular Fibrillation
10. Further improvements envisaged at Carstairs
11. Further Studies on AIDS Prevention Gels Stopped
Post Your Comments:
Other Medicine News:Health News:MU research team makes progress toward 'printing' organs 2Health News:MU research team makes progress toward 'printing' organs 3Health News:Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: 2Health News:Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: 3Health News:Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: 4Health News:NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes 2Health News:NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes 3Health News:NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes 4Health News:NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes 5Health News:NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes 6Health News:'AHF/India Cares' Provides Second-line AIDS Drugs to Activists in India 2Health News:'AHF/India Cares' Provides Second-line AIDS Drugs to Activists in India 3Health News:NIH grant advances dentistry school's work on psychosocial stress 2Health News:NIH grant advances dentistry school's work on psychosocial stress 3Health News:Energy Drinks Could Pose Blood Pressure Risks 2
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3The American Association for Cancer Research Congratulates President Elect on Nobel Prize 58890 1The American Association for Cancer Research Congratulates President Elect on Nobel Prize 58890 2The American Association for Cancer Research Congratulates President Elect on Nobel Prize 58890 3The American Association for Cancer Research Congratulates President Elect on Nobel Prize 58890 4Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 1Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 2Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 3Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 4Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 1Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 2Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 3Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 4
Other Medicine Technology:Ridge Diagnostics, Inc. Awarded Phase 2 National Science Foundation Grant 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12